These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2525295)

  • 21. Effects of loratadine (SCH 29851) in suppression of histamine-induced skin wheals.
    Kassem N; Roman I; Gural R; Dyer JG; Robillard N
    Ann Allergy; 1988 Jun; 60(6):505-7. PubMed ID: 2968060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics of loratadine in normal geriatric volunteers.
    Hilbert J; Moritzen V; Parks A; Radwanski E; Perentesis G; Symchowicz S; Zampaglione N
    J Int Med Res; 1988; 16(1):50-60. PubMed ID: 2965043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis.
    Horak F; Bruttmann G; Pedrali P; Weeke B; Frølund L; Wolff HH; Christophers E
    Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clarityn--a 2-year follow-up study and comparison with Teldanex].
    Lakartidningen; 1992 May; 89(20):1811-2. PubMed ID: 1350801
    [No Abstract]   [Full Text] [Related]  

  • 26. Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man.
    Roman IJ; Kassem N; Gural RP; Herron J
    Ann Allergy; 1986 Oct; 57(4):253-6. PubMed ID: 2945499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Excessive immune reactions. Effective suppression with Loratadine].
    Hautarzt; 1996 Sep; 47(9 Suppl):1-2. PubMed ID: 9022380
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential association of mast cells with coronavirus disease 2019.
    Theoharides TC
    Ann Allergy Asthma Immunol; 2021 Mar; 126(3):217-218. PubMed ID: 33161155
    [No Abstract]   [Full Text] [Related]  

  • 29. Bioconversion of the antihistaminc drug loratadine by tobacco cell suspension cultures expressing human cytochrome P450 3A4.
    Warzecha H; Ferme D; Peer M; Frank A; Unger M
    J Biosci Bioeng; 2010 Mar; 109(3):288-90. PubMed ID: 20159579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rupatadine in allergic rhinitis and chronic urticaria.
    Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
    Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-spasmogenic effect of cyproheptadine on guinea-pig ileum.
    Reylon V; Siddiqui HH
    Indian J Physiol Pharmacol; 1983; 27(4):342-4. PubMed ID: 6678244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
    Roongapinun S; Wajajamreon S; Fooanant S
    J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of loratadine on mouse models of atopic dermatitis associated pruritus.
    Hossen MA; Fujii Y; Ogawa M; Takubo M; Tsumuro T; Kamei C
    Int Immunopharmacol; 2005 Jul; 5(7-8):1331-6. PubMed ID: 15914337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of various pharmacologic preparations on the viability of Chinese hamster fibroblasts in vitro].
    Beuverova EI; Bragina EV; Gusarova EV; Markova LN
    Biull Eksp Biol Med; 1981 Jun; 91(6):739-40. PubMed ID: 7272495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
    Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
    Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extra- and intracellular oxidant production in phorbol myristate acetate stimulated human polymorphonuclear leukocytes: modulation by histamine and H(1)-antagonist loratadine.
    Drábiková K; Jancinová V; Nosál R; Pecivová J; Macicková T
    Inflamm Res; 2006 Apr; 55 Suppl 1():S19-20. PubMed ID: 16547821
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
    Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
    Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loratadine is viable in patients with geriatric rhinitis.
    Wasserman N
    Geriatrics; 2002 Dec; 57(12):10; author reply 10. PubMed ID: 12494726
    [No Abstract]   [Full Text] [Related]  

  • 40. [Congestan].
    Bindslev-Jensen C; Frølund L; Svendsen UG
    Ugeskr Laeger; 1987 Nov; 149(46):3122-4. PubMed ID: 2895520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.